Pharma investors should strategize trades around obesity drug offerings, says Grasso Global CEO

Steve Grasso, Grasso Global CEO, joins 'Power Lunch' to discuss how to trade the news of Kroger's opioid settlement, momentum growing in the biotech sector, and how Snowflake could benefit from AI.